INTRODUCTION
============

Stem cells have been studied for replacing damaged cells or supporting regeneration of damaged tissue ([@R1]; [@R39]). Human embryonic stem cells (ESCs) have been evaluated as therapeutic cell sources due by their multi-lineage differentiation potential including neural cells ([@R25]), blood cells ([@R14]) and pancreatic *β* -cells ([@R7]). However, clinical use of ESCs is faced with the ethical issue and the risk of teratoma formation ([@R16]). The other cell source is induced pluripotent stem cells (iPSCs). Lately human iPSCs was created ([@R42]; [@R37]) through enforced expression of a limited number of genes critical to maintenance of pluripotency in ESCs. Similar to ESCs, iPSCs have also demonstrated their abilities of self-renewal and differentiation potential to all three germ layers ([@R32]; [@R4]). However, using the exogeneous expression of four genes, including two pluripotency transcription factors (*Oct4* and *Sox2*) and two protooncogenes (*c-Myc* and *Klf4*) ([@R34]), could raise a high risk of tumorigenesis when transplanted *in vivo* ([@R21]).

Adult stem cells do not accompany an ethical issue and there is no report of the teratoma formation after transplantation *in vivo*. Previously, mesenchymal stem cells (MSCs) have been shown to proliferate multiple times *in vitro* and to differentiate into a variety of cell types of mesodermal lineage ([@R23]). Later studies have also shown their differentiation potential into endodermal lineage such as hepatocytes ([@R38]), pancreatic *β*-cells ([@R13]), and ectodermal lineage including neurons ([@R40]). MSCs reside in various tissues including bone marrow, adipose tissue, umbilical cord, and amniotic membrane ([@R22], [@R20]). Although bone marrow-derived stem cells (BM-MSCs) are the most well-known and characterized MSCs, their retrieval from bone marrow accompany a highly invasive procedure. Therefore, many studies have been looking for alternative sources. Human eyelid adiposederived stem cells (HEACs), which could be obtained during plastic surgery, were successfully isolated and have shown the characteristics of neural crest cells. Moreover, they exhibited the typical characteristics of MSC, as revealed by differentiation into mesodermal lineages including adipocyte, osteoblast and chondrocyte, and an endodermal lineage such as insulin-secreting cells ([@R13]). Thus HEACs appear to be useful as cells sources for cell therapeutics.

FBS-containing medium has been the conventional medium for the isolation and cultivation of MSCs ([@R11]). However, using animal derivatives might bring a risk of contamination with bacteriophage, infectious bovine rhinotracheitis, parainfluenza-3, bovine viral diarrhea virus ([@R8]), bacteria, prions, nanobacteria, yeast and endotoxins. A single injection of 10^8^ hMSCs grown under 20% FCS would carry with it approximately 7 to 30 mg of calf serum proteins which might cause immune response to FBS in human patients when they were transplanted ([@R30]). Therefore, researchers are searching for alternative sources for human cell cultivation instead of FBS. Recent studies have suggested human body fluids including autologous serum (autoHS) ([@R41]; [@R31]), allogeneic human serum (alloHS) ([@R17]; [@R35]) umbilical cord blood serum (CBS) ([@R18]; [@R36]) and platelet derivatives ([@R15]; [@R2]), follicular fluid (HFF) ([@R24]) could be promising substitutes. Yet, there have been controversial issues about the advantages of HS, and detailed studies about the effects of human serum on stem cells have not been done.

For the first time, the present study revealed that human adult stem cells could move and form aggregates *in vitro* by the treatment with alloHS. Interestingly, the induction of the aggregation appears be specific to the human body fluids. And the change of expression of cytoskeleton-related genes is observed at HEACs cultivated with 10% HS.

MATERIALS & METHODS
===================

1.. Human allogeneic serum (HS)
-------------------------------

HS was obtained from whole-blood donations of 6 female Asian donors. Blood was drained into sterile 50 ml tube (SPL, Korea) without anticoagulants and allowed to clot overnight at 4°C. They were centrifuged at 3,000 rpm for 30 min, and the supernatant was centrifuged again at 3,000 rpm for 30 min to remove any remaining particles. The six allogeneic human sera were pooled and sterile-filtered through 0.2-μm pores (Millipore, Billerica, MA). After inactivation at 56°C for 30 min, HS was aliquoted into 15 ml tube and stored at --20°C until use.

2.. Isolation and culture of HEACs
----------------------------------

The human eyelid adipose tissue was obtained from five patients aged between 20 and 56 years (mean age, 39.6±5.9 years) undergoing cosmetic surgery with informed consent. They were washed with Dulbecco's phosphate buffered saline (DPBS, Gibco, Grand Island, MA) and treated with 0.075% type I collagenase (Gibco) in DPBS for 30 min at 37 with °C gentle stirring. The supernatant was discarded and mixed with an equal volume of Dulbecco's modified Eagle's medium - low glucose (DMEM-LG, Gibco) supplemented with 10% FBS (Gibco) to neutralize the enzymatic activity. After centrifugation at 3,000 rpm for 10 min, the supernatant was removed and the remaining cell suspension was washed several times with DMEM-LG, and were plated in 25-cm^2^ culture flask (Nunc, Rochester, NY) containing DMEM-LG supplemented with 100 U/ml penicillin (Gibco), 0,1 mg/ml streptomycin (Gibco) 3.7 mg/ml sodium bicarbonate, and 10% FBS. The medium was changed twice a week. Passage 4 HEACs were tested in this study.

3.. Aggregation assay
---------------------

HEACs were seeded in 12-well plate (Costar) at density of 1,000 cells/cm^2^. Cells were cultivated with DMEM-LG containing 10% of HS, CBS, FBS, bovine serum (BS, Gibco), 15% Human follicular fluid (HFF), 5% HS --5% FBS and 0.4% of bovine serum albumin (BSA). Morphology of cells was observed during 18 days of culture. To investigate the timing and number of cells at the beginning chemotactical aggregation, cells were plated on a 12-well dish at a density of 10^2^, 10^3^, 10^4^ or 10^5^ cells/well. The number of cells was counted on the day of beginning of the aggregation. CBS and HFF were kindly donated from CHA Gangnam Medical Center with informed consent.

4.. Reverse transcription-polymerase chain reaction (RT-PCR)
------------------------------------------------------------

Total RNA was isolated using Tri-reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. The concentration and quality of isolated RNA was determined using Nanodrop 2000 spectrophotometer (Thermo fisher scientific, Rockford, IL). The purity of RNA was assessed by determining the ratio of absorbance at 260 nm to that at 280 nm (\>1.8). RT-PCR was carried out using a Techne PCR system TC-100 (Bibby Scientific Ltd., UK). Total 7.5 μg (1 μg /μl) RNA was reverse-transcribed using the following RT mixture: 20 mM MgCl~2~ (BioBasic Inc, Canada), 10×PCR buffer (BioBasic Inc), 10 mM dNTPs mixture (BioBasic Inc), 0.5 mg/ml oligo (d)T^15^ (Bionics), 40 U/ μl RNase inhibitor (BioBasic Inc) and 200 U/ μl AMV-RT (Invitrogen). RT reaction was allowed to occur for 60 min at 37°C, and the resultant cDNA subjected to PCR amplification.

For the conventional PCR, cDNA were amplified using the following PCR mixture: 25 mM MgCl~2~, 10×PCR buffer, 5 U/ μl Taq polymerase, 2.5 mM dNTP, 10 μM sense and antisense primer. Amplification was performed for 35 cycles at a denaturing temperature of 94°C for 30 sec and an extension temperature of 72°C for 30 sec. Annealing temperature was set depending on the species of primer. The PCR products were mixed with 6×lading buffer (0.25% bromophenol blue, 0.25% Xylene cyanol and 40% sucrose) and separated on 3% agarose gels. After electrophoresis, gels were stained with ethidium bromide. DNA signals on the gels were imaged under ultraviolet light using a Bioprofile image analysis system (Vilber Lourmat, Germany). Primers used in this experiment were shown in Table [1](#T1){ref-type="table"}. All PCR mixture components were purchased from Takara. HEACs cultivated with 10% FBS were named HEACs, and HEACs cultivated with 10% HS were named agg-HEACs in this study.

###### 

List of gene-specific primers for the PCR analysis

  ---------------------------------------------------------------------------------------------------------------------------
  Gene                       Primer sequence                           Accession number   Size (bp)   Annealing temperature
  -------------------------- ----------------------------------------- ------------------ ----------- -----------------------
  GAPDH                      5'-gaa ggt gaa ggt cgg agt c-3'\          NM_002046          226         53
                             5'-gaa gat ggt gat ggg att tc -3'                                        

  OCT4                       5'-cga cca tct gcc gct ttg ag-3'\         NM_203289          573         61
                             5'-ccc cct gtc ccc cat tcc ta-3'                                         

  SCF                        5'-cca ttg atg cct tca agg ac-3'\         NM_000899          275         55
                             5'-ctt cca gta taa ggc tcc aa-3'                                         

  THY1                       5'-gtc ctt tct ccc cca atc tc-3'\         NM_006288          242         59
                             5'-ggg aga cct gca aga ctg tt-3'                                         

  Vimentin (VIM)             5'-cct tcg tga ata cca cga cct gc-3'\     NM_003380          321         63
                             5'- ctg cca aga acc tgc agg agg-3'                                       

  CK18                       5'-gag atc gag gct ctc aag ga-3'\         NM_000224          357         57
                             5'-caa gct ggc ctt cag att tc-3'                                         

  GATA4                      5'-tcc ctc ttc cct cct caa at-3'\         NM_002052          192         60
                             5'-tca gcg tgt aaa ggc atc tg-3'                                         

  BMP4                       5'-agc cat gct agt ttg ata cc-3'\         NM_130851          384         55
                             5'-tca ggg atg ctg ctg agg tt-3'                                         

  HLA -ABC                   5'-gta ttt ctt cac atc cgt gtc ccg-3\'\   NM_001242758       394         70
                             5'-gtc cgc cgc ggt cca aga gcg cag-3\'                                   

  HLA- DR                    5'-ctg atg agc gct cag gaa tca t-3\'\     NM_019111          220         60
                             5'-gtg cat tgg cca aca tag ctg-3\'                                       

  AFP                        5'-ttt tgg gac ccg aac ttt cc-3'\         NM_001134          451         57
                             5'-ctc ctg gta tcc ttt agc aac tct-3'                                    

  Brachyury (T)              5'-gag ctc acc aat gag atg at-3'\         NM_003181          335         57
                             5'-ggc tca tac tta tgc aag ga-3'                                         

  NCAM1                      5'-gag ggg gaa gat gcc gtg at-3'\         NM_181315          269         60
                             5'-ata ttc tgc ctg gcc cgg atg gta g-3'                                  

  Nestin(NES)                5'-gcc ctg acc act cca gtt tag-3'\        NM_006617          201         55
                             5'-ggg agt cct gga ttt cct tcc-3'                                        

  MSX1                       5'-cct tcc ctt taa ccc tca cac-3'\        NM_002448          285         57
                             5'-ccg att tct ctg cgc ttt tct-3'                                        

  Slug (SNAI2)               5'-acc tcc tcc aag gac cac agt g-3'\      NM_003068          527         59
                             5'-cag tgt gct aca cag cag cca ga-3'                                     

  GalC                       5'-act tcc aca atc gca tgg aa-3'\         NM_000153          696         55
                             5'-aac ttg gcg tag cgt gaa gtg-3'                                        

  CNPase                     5'-aag atg tca tcc tca ggg gc-3'\         NM_033133          505         59
                             5'-gcg gca gga agt cct tct cca g-3'                                      

  *β*-tubulin III (TUBB3)    5'-gcc aag ttc tgg gaa gtc at-3'\         NM_006086          209         57
                             5'-ggc ctg aag aga tgt cca aa-3'                                         

  MAP2                       5'-gaa gac tcg cat ccg aat gg-3'\         NM_004759          527         59
                             5'-cgc agg ata gga gga aga gac t-3'                                      

  SOX9                       5'-gaa cgc aca tca aga cgg ag-3'\         NM_000346          631         57
                             5'-tct cgt tga ttt cgc tgc tc-3'                                         

  Synaptophysin (SYP)        5'-ttc tgc ctc gct taa agc ct-3'\         NM_003179          537         63
                             5'-atc tgt ctg agc cct gcc-3'                                            

  NEFM                       5'-tgg gaa atg gct cgt cat tt-3'\         NM_005382          333         55
                             5'-aat tgg gcg ttt cca tga ag-3'                                         

  GFAP                       5'-ctg gag gtt gag agg gac aat ct-3'\     NM_002055          317         57
                             5'-tac tgc gtg cgg atc tct ttc-3'                                        

  Fibronectin (FN1)          5'-agc tca tca gca tcc agc ag-3'\         NM_000638          255         60
                             5'-act gtg gct cat ctc cct cc -3'                                        

  Vitronectin (VTN)          5'-caa ggc ctg aga ccc ttc at-3'\         NM_000638          318         58
                             5'- tat ttc ggg ggt aat cag gg-3'                                        

  Heatshock 70 (HSPA1A)      5'-ttc gac gtg tcc atc ctg ac-3'\         NM_005345          260         59
                             5'-atg ccc tca aac agg gag tc-3'                                         

  Heatshock 27 (HSPB1)       5'-ctg gat gtc aac cac ttc gc-3'\         NM_001540          327         58
                             5'-ttt act tgg cgg cag tct ca-3'                                         

  Heatshock 60 (HSPD1)       5'-cca ggg tac tgg ctc ctc at-3'\         NM_199440          349         60
                             5'-ctt ctc gaa gcc ttc ctt gg-3'                                         

  Heatshock 90 (HSP90AB1)    5'-tga gga gga tga cag cgg ta-3'\         NM_007355          266         58
                             5'-caa aaa ggt caa agg gag cc-3'                                         

  Nuclear protein1 (Nupr1)   5'-tcg cac caa gag aga agc tg-3'\         NM_012385          244         60
                             5'-ata agt cct agg ggt ggg gg-3'                                         

  Actinin (ACTN1)            5'-cag aag cga agg gaa gct ct-3'\         NM_001130005       291         57
                             5'-cgc cat att gac gtg gta gg-3'                                         

  Cortactin (CTTN)           5'-aaa gtg gat aag agc gcc gt-3'\         NM_138565          376         59
                             5'-gcc tgt cct cct gct ctt tc-3'                                         

  Palladin (PALLD)           5'-tgc ctg att ctc ttc aac gc-3'\         NM_014431          302         59
                             5'-aag agc acc tca gac acc cc-3'                                         

  Synaptopodin (SYNPO)       5'-gag aag cta cgc tca tcc cc-3'\         NM_001166209       291         59
                             5'-cct tct ccc caa aat gtc gt-3'                                         

  Ezrin (EZR)                5'-aca agt aca aga cgc tgc gg-3'\         NM_003379          259         58
                             5'-act ggg gaa aac aaa cca gg-3'                                         

  Gelsolin (GSN)             5'-cct aag gct ggt gca ctg aa-3'\         NM-001258029       279         58
                             5'-ctt gtt gga gca ggc aaa ga-3'                                         

  Transgelin (TAGLN)         5'-aag cat gtc att ggc ctt ca-3'\         NM_001001522       339         58
                             5'-agt aga ggt gat ggg ggc ag-3'                                         

  Caldesmon (CALD1)          5'-aag ggc ggt ctg gag ttt ta-3'\         NM_033157          333         57
                             5'-tcg cat ctc ctc cct ctt tt-3'                                         
  ---------------------------------------------------------------------------------------------------------------------------

All reagents and chemicals were purchased from the Sigma unless otherwise designated.

RESULTS
=======

1.. Effects of HS on HEAC
-------------------------

HEACs were isolated and proliferated in DMEM-LG supplemented with 10% FBS until passage 3. At passage 4, HEACs were transferred to a medium containing 10% HS in a 12-well dish for 3 weeks without subculture even though they reached 100% confluence. In FBS-containing medium, HEACs did not show any morphological change even after culture for 11 days (Fig. [1A](#F1){ref-type="fig"}). However, as shown in Fig. [1B](#F1){ref-type="fig"}, [C](#F1){ref-type="fig"}, [D](#F1){ref-type="fig"}, when they were cultivated in 10% HS-containing medium, HEACs exhibited a movement which directed to several spots after 11 days of culture. During further culture, migrated cells began to aggregate to form several mass which looked like egg-shape (Fig. [1B](#F1){ref-type="fig"}), C-shape (Fig. [1C](#F1){ref-type="fig"}) or simple cell clump-shape (Fig. [1D](#F1){ref-type="fig"}).

![**Effect of HS on the morphology of HEACs during culture.** A, HEACs were cultivated with 10% FBS for 11 days. B, C, D, Morphology of HEACs cultivated with 10% HS for 11 days. Various shapes of HS-induced aggregates of HEACs. ×40.](devrepro-16-339-g001){#F1}

To examine whether all cells have the same response to HS different donor cells and other medium were tested. Aggregation was not observed in 10% FBS or 0.4% BSA-containing medium. However, 10% HS, and 5% HS plus 5% FBS induced aggregations of HEACs after 9 days of culture for HS and 12 days for 5% HS plus 5% FBS (Fig. [2](#F2){ref-type="fig"}). As early as 9 days following treatment, HEACs started moving to several-specific spots and formed aggregations. Between 9 and 11 days aggregates were observed responded to HS. In the other hands, less HS plus FBS-containing medium also induced aggregation, but starting date was delayed from 9-day to 12-day. These results are showing that HS might act as activator and FBS might act as an inhibitor.

![**Chemotactic aggregation of HEACs during culture in different conditions.** HEACs were cultivated in DMEM-LG containing 10% HS, 10% FBS, 5% HS plus 5% FBS, or 0.4 BSA.](devrepro-16-339-g002){#F2}

2.. Conditions for aggregation
------------------------------

To examine if there is any relationship between cell density and the treatment period, and aggregation of HEACs, cells were seeded at varying densities of 10^2^, 10^3^, 10^4^ or 10^5^ cells per well of a 12-well dish. As shown in Fig. [3A](#F3){ref-type="fig"}, aggregation started after culture for 16.0±1.6 days in 10^2^/well, 12.3±1.3 days in10^3^/well, 10.0 ±0.4 days in 10^3^/well, and 9.0±0.4 days in 10^5^/well. The results show that as the number of seeded cells increase, the aggregation form sooner (*p*\<0.05). To see the exact number of cells at the time of aggregation, cells were harvested from each group on the day the aggregation started and each cell number was counted. When initial cell density was 10^3^, 10^4^ or 10^5^, their total cell numbers at the time of aggregation were 24.0±1.8, 24.3±1.2 and 29.3±2.8×10^4^, respectively (Fig. [3B](#F3){ref-type="fig"}).

![**Chemotactic aggregation in relation to cell number.** A, The culture period required for the aggregation of HEACs seeded at different cell densities. B, Total cell numbers at the time of aggregation of HEACs seeded at different cell densities. a is significantly different from b, *p*\<0.05.](devrepro-16-339-g003){#F3}

There was no significant difference among these conditions. However, when the initial cell density was 10^2^/well, then the total cell number was 15.1±0.2×10^4^, which was significantly smaller to the other group (*p*\<0.05). These results show that HEACs cultivated for 9 days at a density of 15.1×10^4^ cells.

3.. Human body fluid-specific aggregation
-----------------------------------------

To investigate whether the aggregation is human body fluid-specific phenomenon, 10% of CBS, BS, FBS or 15% HFF were tested. Cells were seeded at density of 3.5×10^3^cells/cm^2^ and treated for 18 days. When cells were cultivated with medium containing 10% HS and CBS or 15% HFF, cells began to move into several spots and aggregated, but not in 10% FBS or BS (Fig. [4](#F4){ref-type="fig"}). Average aggregating periods were 10.2± 0.1 days in HS-containing medium, 13.2±0.6 days in CBS-containing medium and 16.4±0.8 days in HFF-containing medium. These results indicate that chemotactic aggregation of HEACs could be induced not only by HS but also by CBS or HFF.

![**Effect of various body fluids on the chemotactic aggregation of HEACs.** There was neither detectable cell movement nor cell aggregate after 7 days of culture inany conditions. However, distinct aggregation was observed in HEACs cultivated for 18 days in HS-, CBS-, HFF-containing media. No behavioral change was seen in HEACs cultivated in BS- or FBS-containing medium. All supplements were added as 10% concentration except HFF which was used at 15%. ×40.](devrepro-16-339-g004){#F4}

4.. Gene expression of HEACs, cultivated in HS-containing medium
----------------------------------------------------------------

To investigate the effect of aggregation phenomenon on the characteristics of HEACS, expression of genes related with stem cells, stress, and cytoskeleton was examined. Agg-HEACs induced with 10% HS were examined their gene expression and it was compared with HEACs cultivated with 10% FBS. It was shown that agg-HEACs express consistently stem cell-related genes of *OCT4, SCF* and *THY1*, mesoderm/endoderm-related genes of *CK18*, endoderm-related genes of *BMP4* (Fig. [5A](#F5){ref-type="fig"}) but not express endoderm-specific *AFP* and mesoderm-specific *Brachyury* (T). Immunerelated gene of *HLA-ABC* was expressed in agg-HEACs but not *HLA-DR*. There was no difference in expression level between HEACs and agg-HEACs. However, interestingly, agg-HEACs did not express *VIM*, and showed lower expression level of *GATA4* gene compared to HEACs cultivated in FBS-containing medium. Previously, we reported that HEACs have neural-crest properties ([@R13]), therefore in this study we confirmed the expression of neural crest-related genes at both HEACs and agg-HEACs. The results showed that both HEACs and agg-HEACs express ectoderm- or neural progenitor-related genes of *NCAM1* and *NES*, neural crest-related genes of *MSX1, SNAI2*, and glial cell-related genes of *GALC* and *CNPase*, neuron-related genes of *TUBB3* and *SOX9*, but they do not express both *GFAP* and *NEFM* genes, related with glial and neuron cells, respectively (Fig. [5B](#F5){ref-type="fig"}). However, it was found that HS-induced aggregated HEACs increase mRNA expression of neuronrelated genes of *MAP2* and *SYP*. On the other hands, to examine whether aggregation phenomenon involve the cellular stress, we investigated the expression of stress-related genes. The results showed that the expression of stress-related genes of *HSPA1A, HSPB1, HSPD1, HSP90AB1* and *Nupr1*of agg-HEACs does not changed when it compared with HEACs cultivated with 10% FBS (Fig. [5C](#F5){ref-type="fig"}). Finally, to define the expression of ECM- and actin-related genes on agg-HEACs, mRNA expression was investigated. It was observed that both HEACs and agg-HEACs express ECM-related genes of *FN1* and *VTN* and actin-related genes of *ACTN, CTTN, SYNPO, EZR, GSN, TAGLN*, and *CALD1* with no significant difference in expression levels while the expression of actin-related gene of *PALLD* was markedly decreased in agg-HEACs.

![**Gene expression profile of HEACs during culture in HS-containing medium.** (A) Expression of stem cell-related genes (A), neuronal cell-related genes (B) ECM-, stress-, and cytoskeleton-related genes (C) of HEACs cultivated with 10% FBS (HEACs) and 10% HS (agg- HEACs) are observed using the RT-PCR. Numbers represent cell replicates.](devrepro-16-339-g005){#F5}

DISCUSSION
==========

In this study we found that HEACs move and form the aggregate by the treatment of HS *in vitro* and the aggregation of HEACs is specifically induced by the human body fluids.

Many researchers have extensively studied the HS as FBS-substitute for expansion of MSCs. For example, it is reported that autoHS shows similar effect with FBS on characteristics of MSCs including both expansion and multi-differentiation potential into adipocyte and osteoblast ([@R31]). Some reports showed that autoHS is better than FBS in proliferation capacity of BM-MSCs ([@R28]). These results suggest that autoHS might be a suitable candidate for cultivation of MSCs. However, it is practically difficult to apply for cell therapy since a large amount of auto-HS should be obtained from a single donor for cultivation of cells for transplantation. Therefore, it has been suggested that alloHS can be alternatively used for cultivation of MSCs as a feasible supplement of FBS because it can be easily obtained ([@R17]; [@R15]). However, there has been a lot of controversy about alloHS for cultivation of MSCs. It has been shown that MSCs including umbilical cord-derived stem cells (UCSCs) have high proliferative potential in presence of alloHS. It showed that alloHS support a homogenous morphology and a stable expression of stem cells-related genes during long-term expansion ([@R10]). On the other hands, it has been reported that cells cultivated with alloHS enter senescence earlier than cells cultured in presence of FBS although it shows a much higher cumulative population doubling numbers until passage 6 ([@R15]). Also, some researchers argued that commercial alloHS can lead poor cellular yields, a notable cell death and morphological deterioration ([@R30]).

CBS, another human body fluid, can be used for FBS-substitute for cultivation of MSCs as a safe and unique humanized culture condition. It has been reported that CBS support to enhanced self-renewal capacity and osteogenic potential of MSCs ([@R12]). Interestingly, it showed that MSCs cultured with CBS was detached from the flask at passage 3, although cells showed high replicative ability until passage 2, whereas cells cultured in presence of FBS were continued to grow up as a monolayer ([@R29]). This report supports our aggregation phenomenon of HEACs which move and form the cell aggregation in culture medium containing 10% CBS. Follicular fluid (FF) is a liquid that surrounds the oocyte with the attached follicular cells. It is well known that FF contains various biological active proteins that affect follicular growth and maturation ([@R33]). Recently, it is reported that the FF promote the proliferation of goat umbilical cord-derived MSCs (UCMSCs). On the other hands, higher concentration of follicular fluid (10 %) showed the induction of UCMSCs into oocyte-like cells.

In this study, we observed that HEACs form aggregates *in vitro* by the cultivation of human body fluids including alloHS, CBS, and HFF. Until now, there are not any reports about the aggregates formation of MSCs by allogeneic HS, CBS and HFF. They could not be observed this phenomenon because subculture of cells is usually performed before cells reach the confluence on the flask. In this study, we found that HEACs form the aggregation after the confluence by alloHS, CBS, and HFF but not by FBS and BS. It showed that it takes 4 5 days to aggregate after confluence in culture medium containing 10% alloHS and at least 9 days from initial cultivation at seeding density of 2.6×10^4^ cells/cm^2^. When HEACs are cultivated with CBS or HFF, the culture period for the formation of aggregate of HEACs increased than allo-HS. From these results, we suggest that human follicular fluid including HS, CBS and HFF have a special factor to induce the aggregation of cells. Since the aggregation was not induced by FBS and BS, further studies should be performed to investigate whether this phenomenon is only observed with human body fluids. It can be disclosed using other animal fluids such as mouse and rabbit. Furthermore, it needed to be examined whether the aggregates formation of cells is only occurred at human stem cells or not.

To investigate the effect of aggregation phenomenon on the characteristics of HEACS, expression of genes related with stem cells, stress, and cytoskeleton was examined. As a result, agg-HEACs induced by alloHS showed remarkably low expression level of *VIM* gene, stem cell-related marker gene. Vimentin is a type III intermediate filament (IF) and it is known as a major cytoskeletal component of mesenchymal cells ([@R5]). In addition, the results showed that expression of *MAP2* and *SYP*, neural crest-related genes, increase on agg-HEACs compared to HEACs. MAP2 serves to stabilize microtubules (MT) growth by crosslinking MT with intermediate filaments and other MT. It is known that the increase of MAP2 is observed at the neuron which exhibiting a rapid neurite extension ([@R3]). These results are consistent with the findings of down-regulated expression of *PALLD* gene, a component of actin-containing microfilaments. In recent study, it has been found that downregulation of palladin by small hairpin RNA (shRNA) enhances invasive migration, indicating that the lower expression of palladin helps the cell migration ([@R6]). As the internal cytoskeleton of eukaryotic cells is composed of actin microfilaments, microtubules, and intermediate filaments, our results revealed that all three components of internal cytoskeleton are changed by the aggregation of cells. Taken together, our study demonstrates that agg-HEACs form with the change of expression of various cytoskeleton-related genes.

It is known that various environments such as temperature shock, oxygen shock, nutrient deprivation, and confluence cause the stress to the cells ([@R26]; [@R19]; [@R27]). To examine whether an aggregation structure can be an external factor of the stress, expression of stress-related genes including *HSPA1A, HSPB1, HSPD1, HSP90AB1* and *Nupr1* were examined in agg-HEACs. As shown in Fig. [5C](#F5){ref-type="fig"}, there were no differences of gene expression in both HEACs and agg-HEACs. This result suggests that stress might not be influenced when HEACs were cultivated with 10% HS. These are consistent with previous reports that demonstrated a stable phenotype of MSCs without the cell density ([@R9]).

In summary, these results demonstrated the movements and aggregation of HEACs by human body fluids, including HS, CBS and HFF at the first time. And it revealed that the expression of cytoskeleton-related genes is changed by cultivating with HS.
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